Work

Venetoclax with Low-Dose Cytarabine Induces Rapid, Deep, and Durable Responses in Previously Untreated Older Adults with AML Ineligible for Intensive Chemotherapy

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-118729

Authors: Andrew Wei, Stephen A. Strickland, Jing-Zhou Hou, Walter Fiedler, Tara L Lin, Roland B. Walter, Anoop K Enjeti, Wan-Jen Hong, Brenda Chyla, Relja Popovic, Kaffa Fakouhi, Tu Xu, John Hayslip, Gail J. Roboz

Institutions: The Alfred Hospital, Monash University, Vanderbilt University Medical Center, UPMC Hillman Cancer Center, University Medical Center Hamburg-Eppendorf, University Cancer Center Hamburg, University of Kansas, Fred Hutch Cancer Center, Calvary Mater Newcastle Hospital, Genentech, AbbVie (United States), Cornell University, Weill Cornell Medicine

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2902959791

Cites:

Cited by: 33

Related to: 10